Showing results (61-70 of 127) with videos related to
Sort By:
Pageof 13
Blood|December 21, 2011
IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processingFrancesca Spadaro, Caterina Lapenta, Simona Donati, et al.Blood|May 26, 2009
CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cellsManuela Del Cornò, Alessandro Michienzi, Andrea Masotti, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
APC activation by IFN-alpha decreases regulatory T cell and enhances Th cell functionsLuigia Pace, Sara Vitale, Beatrice Dettori, et al.Immunobiology|November 25, 2010
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activityLaura Lattanzi, Carmela Rozera, Diego Marescotti, et al.Blood|June 14, 2003
Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophagesLaura Fantuzzi, Francesca Spadaro, Giuliana Vallanti, et al.The Journal of Experimental Medicine|July 23, 2003
Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alphaCaterina Lapenta, Stefano M Santini, Mariantonia Logozzi, et al.Blood|October 4, 2003
IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatmentLucia Gabriele, Paola Borghi, Carmela Rozera, et al.Journal of Translational Medicine|May 19, 2011
Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatmentsEleonora Aricò, Luciano Castiello, Francesca Urbani, et al.Vaccine|April 7, 2005
Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal levelLaura Bracci, Irene Canini, Simona Puzelli, et al.International Journal of Cancer|October 5, 2017
Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamideCarla Buccione, Alessandra Fragale, Federica Polverino, et al.Pageof 13